Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Mar 2, 2023
- Accession no.
- 0001225208-23-003166
- Filed
- Mar 2, 2023
- Trade date
- Mar 1-2, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.93M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +16,863 | $17.26 | +$291,055.38 | 302,821 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +15,086 | $16.31 | +$246,052.66 | 317,907 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +13,661 | $13.08 | +$178,685.88 | 331,568 | Direct | |
| Mar 1, 2023 | Common Stock | SSaleDisposed | −75,610 | $46.64F2 | −$3,526,450.4 | 255,958 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −30,000 | $46.66F3 | −$1,399,800 | 225,958 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −16,863 | $0.00 | $0 | 33,728 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −15,086 | $0.00 | $0 | 30,173 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −13,661 | $0.00 | $0 | 13,662 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.437 to $46.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.575 to $46.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.